3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Neoplasms
19
Breast Neoplasms
15
Prostatic Neoplasms
14
Colorectal Neoplasms
14
Hematopoietic and Lymphatic System Neoplasm
13
Lung Neoplasms
11
Ovarian Neoplasms
5
Multiple Myeloma
5
Hematologic Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Malignant Solid Neoplasm
4
Hematopoietic and Lymphoid System Neoplasm
4
Depression
4
Uterine Cervical Neoplasms
3
Neoplasm Metastasis
3
Lymphoma
3
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Anxiety Disorders
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia, Myeloid, Acute
2
Interventions
Cisplatin
13
Cetuximab
10
Radiotherapy
7
pembrolizumab
4
Pemetrexed
4
Fluorouracil
4
Docetaxel
4
Gemcitabine
3
durvalumab
2
Surveys and Questionnaires
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Narrow Band Imaging
2
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
2
Gefitinib
2
Drug Therapy
2
Carboplatin
2
tremelimumab
1
niraparib
1
monalizumab
1
linrodostat
1
dostarlimab
1
capmatinib
1
X-Rays
1
Vitamin B 12
1
Tirapazamine
1
Tablets
1
Sugars
1
Radiotherapy, Adjuvant
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Laryngeal Diseases
×
Interviews as Topic
×
Clear all
NCT01647477
2026-03-13
DEREDIA
Centre Oscar Lambret
Phase NA
Terminated
90 enrolled